(Inclusive of all taxes)
Biovac A Vaccine is indicated for active immunization against infection caused by a human hepatitis-A virus (HAV) in persons over one and a half years of age. Biovac A Vaccine can be used for primary immunization. Biovac A Vaccine is recommended for pre-exposure prophylaxis of individuals at increased risk of infection and post-exposure prophylaxis.
Biovac A Vaccine is a freeze-dried live attenuated hepatitis A vaccine administered by injection and it's usually given in two doses, with the second dose given six to 12 months after the first. This type of Biovac A Vaccine is effective in preventing hepatitis A infection and is considered safe for use in people 1 year of age and older.
Biovac A Vaccine only protects against hepatitis A. There is a separate vaccine available for hepatitis B. There is also a combination of hepatitis A and hepatitis B vaccines that offers protection for both viruses. There is no vaccine for hepatitis C at this time.
Biovac A Vaccine should not be given to individuals who have known hypersensitivity to any of its components. Additionally, it is recommended to avoid administering the Biovac A Vaccine during a severe fever.
Biovac A Vaccine may cause some common side effects including nausea, pain, abdominal pain, anaphylactic reaction, convulsion, fatigue and headache, loss of appetite, tenderness, and vomiting. It is recommended to consult with a doctor if these symptoms persist or cause discomfort. Your doctor can provide guidance on how to manage any side effects.
Before taking Biovac A Vaccine, inform your doctor or nurse if you have any pre-existing conditions such as kidney or liver disease, fever, or other diseases, or if you are currently taking any medications, herbs, vitamins, etc. Additionally, let them know if you are pregnant or breastfeeding.
Prevention of Hepatitis A infection: Biovac A Vaccine is used to protect against Hepatitis A infection of the liver caused by the hepatitis A virus. It is primarily spread through contact with an infected person or by consuming contaminated food or water. Symptoms include fatigue, nausea, stomach pain, and jaundice (yellowing of the skin and eyes). If you are taking Biovac A. You must follow an additional precaution against infection however practising good hygiene such as washing hands frequently, especially before eating or preparing food, can also help reduce your risk. Avoiding close contact with people who are carriers of the virus and practising safer sex can further decrease your risk.
The Biovac A Vaccine is used for preventing hepatitis A, an infection that can cause liver inflammation. The Biovac A Vaccine works by stimulating the immune system to create the antibodies necessary to combat the virus. Biovac A Vaccine is typically recommended for individuals who have a higher likelihood of contracting hepatitis A, and is administered via injection into a muscle. To achieve the best possible protection, it is suggested to receive the vaccine at least two weeks prior to any potential exposure to the virus.
Like all medications, Biovac A Vaccine can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
The Biovac A Vaccine is given through an injection into a muscle. Usually, it is recommended to receive Biovac A Vaccine in two doses, with the second dose administered 6 to 12 months after the first. It is essential to follow the instructions given by the doctor or the package insert when administering the Biovac A Vaccine.
The Biovac A Vaccine works by introducing a small, non-harmful component of the hepatitis A virus into the body. This triggers the immune system to create antibodies against the virus, which remain in the body and provide protection against future hepatitis A infections. The Biovac A Vaccine does not contain live virus and therefore cannot cause the disease. When an individual who has been vaccinated is exposed to the virus, their immune system will recognize it and produce the necessary antibodies to combat it, preventing the person from becoming ill.
It is generally not recommended to drink alcohol while taking Biovac A Vaccine. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Use of Biovac A Vaccine may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Biovac A Vaccine during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
It is not recommended to breastfeed while taking Biovac A Vaccine. Biovac A Vaccine may pass into breast milk and harm the infant. If you are breastfeeding and taking Biovac A Vaccine, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
It is uncertain if the Biovac A Vaccine affects one's ability to drive. If any symptoms that impair focus and reaction occur, do not operate a vehicle.
Biovac A Vaccine should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Biovac A Vaccine and report any unusual symptoms or changes in kidney function to their doctor. The dose of Biovac A Vaccine may need to be adjusted in patients with kidney disease.
Biovac A Vaccine should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Biovac A Vaccine and report any unusual symptoms or changes in liver function to their doctor. The dose of Biovac A Vaccine may need to be adjusted in patients with liver disease.
1, Immunogenicity And Safety Of Live Attenuated Hepatitis A Vaccine (biovac-a) In Healthy Indian Children, Dovepress, available Form
2. Long-term Immunogenicity Of Single Dose Of Live Attenuated Hepatitis A Vaccine In Indian Children, Sheila Bhave, Amita Sapru, Ashish Bavdekar, Vaibhav Kapatkar And Amey Mane. From Department Of Pediatrics, Kem Hospital Research Centre, Pune; And department Of Medical Affairs, Wockhardt Limited, Mumbai; India. Available Form
3. Havrix 1440 (adult) / 720 (junior), Inactivated Hepatitis A Vaccine (adsorbed) Ip, GlaxoSmithKline Pharmaceuticals Limited, India, Product Leaflet
4. Havrix Junior Monodose Vaccine, Hepatitis A Vaccine (inactivated, Adsorbed). 720 Elisa Units/ 0.5 Ml. Suspension For Injection In A Pre-filled Syringe, Gsk, Available Form